NEW

ETHICON LAUNCHES VISTASEAL FIBRIN SEALANT

Many patients today are entering the operating room with multiple factors that can cause disruptive bleeding during surgery, which can be challenging to manage and potentially dangerous. To help address this, Johnson & Johnson Medical Devices Companies* announced...

Going digital: Using real data to prevent infection

By Dustin Rahlf, Director of Healthcare Digital Solutions at Ecolab While AI & robot enabled surgeries are capturing headlines, real-time digital dashboards and predictive analytics may be the overshadowed sidekick that enables a safer operating room (OR). It is...

AORN Updates Guideline on Sterilization Packaging

By Susan Klacik The primary objective of sterilization packaging is to maintain the sterile integrity of the packaged contents until they are used. Many factors influence this outcome and the Association of periOperative Registered Nurses’ (AORN’s) newly updated...

ASCs Embrace Nation’s Renewed Focus on Healthcare Quality

By Bill Prentice As the Democratic presidential candidates continue to define their plans for delivering affordable, accessible healthcare and members of Congress on both sides of the aisle continue to explore ways to cut the cost of that care without sacrificing...

Eloquest Healthcare, Vancive Medical Technologies Launch Dressings

Vancive Medical Technologies, an Avery Dennison business, and Eloquest Healthcare Inc. have partnered to develop an innovative post-operative dressing that contains an antimicrobial agent called chlorhexidine gluconate (CHG). The antimicrobial properties of CHG inhibit microbial growth within the dressing.

CHG is extremely difficult to incorporate in an absorbent adhesive dressing, making the development of the BeneHold CHG platform a significant technical accomplishment for Vancive. The Eloquest Healthcare ReliaTect Post-Op Dressings with CHG are the first to combine CHG in an absorbent, transparent and waterproof design.

“ReliaTect post-operative dressings are a natural fit for our BeneHold CHG platform, and the needs of patients and clinicians,” said Kirsten Newquist, general manager for Vancive Medical Technologies. “We look forward to further expanding our CHG technology to many more applications.”

ReliaTect is available in small and large sizes with a transparent window for surgical site visualization, and a nonwoven border that facilitates dressing application and provides additional securement during wear. The dressings comfortably adhere to the skin, absorb fluids and protect the site from external contaminants.

ReliaTect Post-Op Dressings with CHG are now commercially available from Eloquest Healthcare in the United States. The device received 510(k) clearance from the FDA in March and is now available nationwide. Eloquest Healthcare is the exclusive distributor of the dressings in the United States and Canada.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X